Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes Qingqu GuoMuxing KangYulian Wu Original Paper 20 February 2010 Pages: 1627 - 1631
Feasibility of 125I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma Chuanxing LiFujun ZhangPeihong Wu Original Paper 21 February 2010 Pages: 1633 - 1640
Knockdown of Li-cadherin increases metastatic behaviors of LoVo cells Qiong-Fang YuWei-Guo DongJian-Lin Ren Original Paper 04 March 2010 Pages: 1641 - 1649
Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma Kristina SchwambornRené C. KriegAxel Wellmann Original Paper 21 February 2010 Pages: 1651 - 1655
Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer Stefan S. BozhanovSvetla G. AngelovaElena I. Georgieva Original Paper 23 February 2010 Pages: 1657 - 1669
Beta2-GPI: a novel factor in the development of hepatocellular carcinoma Xue JingYun-Feng PiaoPu-Jun Gao Original Paper 04 March 2010 Pages: 1671 - 1680
Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil David PáezLaia ParéMontserrat Baiget Original Paper 18 February 2010 Pages: 1681 - 1689
Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution Marcel SeizUlrich KrafftJochen Tuettenberg Original Paper 23 February 2010 Pages: 1691 - 1695
Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells Zhenyu DingLi YangHoujie Liang Original Paper Open access 09 March 2010 Pages: 1697 - 1707
Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome Isabell D. WitzelKarin Milde-LangoschVolkmar Müller Original Paper 04 March 2010 Pages: 1709 - 1718
Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer Dan ZhouShao-Qiang ChengDa Pang Original Paper 13 March 2010 Pages: 1719 - 1727
Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis Karin OechsleVictoria Lange-BrockMaike de Wit Original Paper 04 March 2010 Pages: 1729 - 1735
Expression and clinical significance of EGFL7 in malignant glioma Chun-hai HuangXue-jun LiXian-rui Yuan Original Paper 06 March 2010 Pages: 1737 - 1743
Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma Xiaohong ShenNa LiQiang Li Original Paper 10 March 2010 Pages: 1745 - 1754
Clinical investigation of malignant mesothelioma in Japan Nobukazu FujimotoKeisuke AoeTakumi Kishimoto Original Paper 06 March 2010 Pages: 1755 - 1759
Targeting monoamine oxidase A in advanced prostate cancer Vincent FlamandHongjuan ZhaoDonna M. Peehl Original Paper 04 March 2010 Pages: 1761 - 1771
PI3K/Akt and GSK-3β prevents in a differential fashion the malignant phenotype of colorectal cancer cells Wallace Martins de AraújoFlavia Castello Branco VidalJose Andres Morgado-Diaz Original Paper 05 March 2010 Pages: 1773 - 1782
t (11;18)(q21;q21) chromosome translocation (A1446-M1150) of MALT lymphoma in buccal mucosa Toshiaki TanakaMituyoshi Iino Letter to the Editor 31 July 2010 Pages: 1783 - 1785